2026 Single-Cell Cancer Biology Gordon Research Conference and Gordon Research Seminar

The 2026 Gordon Research Conference in Single Cell Cancer Biology (GRC-SCCB) is a 7-day conference that will be held March 21-27 at the Four Points Sheraton hotel in Ventura, California. The rapid advancement of single cell technologies has provided an unprecedented opportunity to answer longstanding questions about the impact of intratumor heterogeneity, cellular plasticity, clonal evolution, tumor-stroma interactions, and mechanisms of metastasis and therapeutic resistance. These questions have been difficult to address through characterization of bulk tissue samples, which are limited to providing an average signal from a complex population of cells. cancer, such as The specific aims of the 2026 GRC-SCCB are to 1) present new discoveries in cancer made using single cell approaches, 2) highlight technological and analytic advances for analyzing single cell data, 3) foster cross-disciplinary collaboration to drive new innovation and discovery, 4) promote clinical application of new technologies and discoveries, and 5) provide a forum for the scientific and career development of junior investigators. The meeting will bring together experts in industry and academia, with wide-ranged expertise in cancer biology, imaging, engineering, single cell technologies, computational biology, and clinical oncology to foster new ideas, collaborations, and leadership for the coming decade of rapid progress in in the field of single cell cancer biology. Project Number: 1R13CA310751-01 | Fiscal Year: 2026 | NIH Institute/Center: National Cancer Institute (NCI) | Principal Investigator: Ken Chen | Institution: GORDON RESEARCH CONFERENCES, East Greenwich, RI | Award Amount: $10,000 | Activity Code: R13 | Study Section: Special Emphasis Panel[ZRG1 SCIL-S (80)] View on NIH RePORTER: https://reporter.nih.gov/project-details/11320601